Traws Pharma, Inc. — Director's Dealing 2017

Jan 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2017-01-17

Reporting Person: Kumar Ramesh (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-17	Stock Option (right to purchase)	$2.70	A	44027	Acquired	2027-01-17	Common Stock (44027)	Direct

Footnotes

F1: These options vest over three years in 36 equal monthly installments.